BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32178625)

  • 1. The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome.
    Tian Z; Zhuang X; Luo M; Yin W; Xiong L
    BMC Gastroenterol; 2020 Mar; 20(1):73. PubMed ID: 32178625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Sun Q; Jia Q; Song L; Duan L
    Medicine (Baltimore); 2019 Feb; 98(7):e14513. PubMed ID: 30762787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis.
    Ju X; Jiang Z; Ma J; Yang D
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.
    Tana C; Umesaki Y; Imaoka A; Handa T; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2010 May; 22(5):512-9, e114-5. PubMed ID: 19903265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of fecal metabolic profiles in patients with irritable bowel syndrome with predominant diarrhea investigated using
    Lee JS; Kim SY; Chun YS; Chun YJ; Shin SY; Choi CH; Choi HK
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13830. PubMed ID: 32125749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of fecal volatile organic metabolites in irritable bowel syndrome.
    Ahmed I; Greenwood R; Costello Bde L; Ratcliffe NM; Probert CS
    PLoS One; 2013; 8(3):e58204. PubMed ID: 23516449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.
    Calderon G; Patel C; Camilleri M; James-Stevenson T; Bohm M; Siwiec R; Rogers N; Wo J; Lockett C; Gupta A; Xu H; Shin A
    J Clin Gastroenterol; 2022 Mar; 56(3):234-242. PubMed ID: 33780215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
    Farup PG; Rudi K; Hestad K
    BMC Gastroenterol; 2016 Apr; 16(1):51. PubMed ID: 27121286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Moser AM; Spindelboeck W; Halwachs B; Strohmaier H; Kump P; Gorkiewicz G; Högenauer C
    Eur J Nutr; 2019 Oct; 58(7):2767-2778. PubMed ID: 30251020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
    Hod K; Sperber AD; Maharshak N; Ron Y; Shapira I; David Z; Rogowski O; Berliner S; Shenhar-Tsarfaty S; Dekel R
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13464. PubMed ID: 30240124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.